In a patient with opioid use disorder, what is the primary goal of medication-assisted treatment?

The primary goal of medication-assisted treatment (MAT) in patients with opioid use disorder is to decrease opioid dependence and promote stability. MAT utilizes medications such as methadone, buprenorphine, or naltrexone alongside counseling and behavioral therapies. This multimodal approach aims to reduce cravings, alleviate withdrawal symptoms, and enhance overall functioning, allowing individuals to lead healthier, more stable lives.

Achieving stability means that patients can manage their recovery effectively without the chaos and risks associated with illicit opioid use. While complete withdrawal from all substances might seem like a goal, the focus is rather on engaging patients in treatment that allows them to reduce harm and gradually work towards recovery. Maximizing opioid prescription contradicts the principles of MAT since the intent is not to increase opioid use but to stabilize and support recovery. Similarly, increasing opioid intake over time would directly oppose the treatment objective, which is to help individuals manage their dependence and ultimately work towards a better quality of life free from problematic use.